Ge, S.; Lepic, K.; Bhindi, R.; Berg, T.; Khalaf, D.; Leber, B.; Radford, M.; Walker, I.; Davies, G.; Garcia-Horton, A.
Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma. Curr. Oncol. 2025, 32, 118.
https://doi.org/10.3390/curroncol32020118
AMA Style
Ge S, Lepic K, Bhindi R, Berg T, Khalaf D, Leber B, Radford M, Walker I, Davies G, Garcia-Horton A.
Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma. Current Oncology. 2025; 32(2):118.
https://doi.org/10.3390/curroncol32020118
Chicago/Turabian Style
Ge, Shiliang, Kylie Lepic, Ravi Bhindi, Tobias Berg, Dina Khalaf, Brian Leber, Michael Radford, Irwin Walker, Gwynivere Davies, and Alejandro Garcia-Horton.
2025. "Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma" Current Oncology 32, no. 2: 118.
https://doi.org/10.3390/curroncol32020118
APA Style
Ge, S., Lepic, K., Bhindi, R., Berg, T., Khalaf, D., Leber, B., Radford, M., Walker, I., Davies, G., & Garcia-Horton, A.
(2025). Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma. Current Oncology, 32(2), 118.
https://doi.org/10.3390/curroncol32020118
